Home » ROCHE 3Q SALES GET HELP FROM TAIL PRODUCTS
ROCHE 3Q SALES GET HELP FROM TAIL PRODUCTS
Roche's (RHHBY) strong 3Q sales report includes strong performance from so-called tail products, says Merrill Lynch analyst. Sales of tail products, which contain a mixture of newly-launched and older products, remained strong. "The results serve to underpin the positive earnings momentum, which we continue to see from Roche, supporting our buy rating."
New Ratings (http://www.newratings.com/analyst_news/article_1070525.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May